| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |